About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

US Scientists Convert Cancer Cells' Protein-bodyguard into Their Assassin

by Tanya Thomas on November 28, 2008 at 11:35 AM
Font : A-A+

 US Scientists Convert Cancer Cells' Protein-bodyguard into Their Assassin

Protein Bcl-2, infamous in medicine as a cancer cell bodyguard, has now been successfully turned by American researchers into an effective cancer cell assassin.

Researchers at Oregon State University and the Burnham Institute for Medical Research in La Jolla, California, say that they that they have developed a peptide that converts the Bcl-2 protein from a cancer cell's friend to a foe.

Advertisement

"Now we can force this protein to backstab the cancer cell where it resides," said Siva Kolluri, an assistant professor of cancer biology in the environmental and molecular toxicology department at OSU, and the lead author of the study published in the journal Cancer Cell.

The researcher described the peptide NuBCP-9, which his key to the conversion, as a string of nine amino acids that bind to Bcl-2 and attack the mitochondria, the powerhouse of cells.
Advertisement

They revealed that they derived the peptide from Nur77, a nuclear receptor that can cause cells to die.

During the study, the researchers injected the peptide and its mirror-image molecule into mice, and found the cancer cells dying and the tumors shrinking.

They also found that a structurally mirrored-image stable peptide worked as well as the original peptide.

Kolluri is of the opinion that the new findings may pave the way for cancer-fighting drugs that target Bcl-2.

He revealed that Bcl-2 is an attractive drug target because its levels are elevated in a majority of human cancers, and it is responsible for cancer cells' resistance to many chemotherapeutic drugs and radiation.

Michael Melner, a scientific program director at the American Cancer Society in Atlanta, welcomed the new findings.

He said that one of the next steps for the research team would be to determine what types of cancer and what stages of the disease this deadly Bcl-2 converter would combat.

Source: ANI
TAN/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Biopsy-Introduction
Encyclopedia section of medindia explains in brief Introduction To Biopsy...
Liver Cancer - Animation
Liver is the largest organ inside the human body. It performs 500 different functions and processes ...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use